CVSG Stock Overview
CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
CVSG passed our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£19.50|
|52 Week High||UK£28.35|
|52 Week Low||UK£14.75|
|1 Month Change||-13.14%|
|3 Month Change||-19.75%|
|1 Year Change||27.45%|
|3 Year Change||195.01%|
|5 Year Change||84.48%|
|Change since IPO||753.39%|
Recent News & Updates
A Look At The Fair Value Of CVS Group plc (LON:CVSG)
How far off is CVS Group plc ( LON:CVSG ) from its intrinsic value? Using the most recent financial data, we'll take a...
Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
CVS Group plc ( LON:CVSG ), is not the largest company out there, but it saw a double-digit share price rise of over...
|CVSG||GB Healthcare||GB Market|
Return vs Industry: CVSG exceeded the UK Healthcare industry which returned 20.6% over the past year.
Return vs Market: CVSG exceeded the UK Market which returned 7.8% over the past year.
|CVSG Average Weekly Movement||3.9%|
|Healthcare Industry Average Movement||3.7%|
|Market Average Movement||5.0%|
|10% most volatile stocks in GB Market||10.7%|
|10% least volatile stocks in GB Market||2.5%|
Stable Share Price: CVSG is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: CVSG's weekly volatility (4%) has been stable over the past year.
About the Company
|1999||7,241||Richard William Fairman||https://www.cvsukltd.co.uk|
CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses.
CVS Group Fundamentals Summary
|CVSG fundamental statistics|
Is CVSG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CVSG income statement (TTM)|
|Cost of Revenue||UK£288.20m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Mar 24, 2022
|Earnings per share (EPS)||0.27|
|Net Profit Margin||3.78%|
How did CVSG perform over the long term?See historical performance and comparison
0.3%Current Dividend Yield
Is CVS Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CVSG (£19.5) is trading below our estimate of fair value (£27.06)
Significantly Below Fair Value: CVSG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CVSG is poor value based on its PE Ratio (71.7x) compared to the UK Healthcare industry average (20.4x).
PE vs Market: CVSG is poor value based on its PE Ratio (71.7x) compared to the UK market (18.9x).
Price to Earnings Growth Ratio
PEG Ratio: CVSG is poor value based on its PEG Ratio (4.2x)
Price to Book Ratio
PB vs Industry: CVSG is overvalued based on its PB Ratio (7.2x) compared to the GB Healthcare industry average (2.9x).
How is CVS Group forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVSG's forecast earnings growth (17.2% per year) is above the savings rate (0.9%).
Earnings vs Market: CVSG's earnings (17.2% per year) are forecast to grow faster than the UK market (12.1% per year).
High Growth Earnings: CVSG's earnings are forecast to grow, but not significantly.
Revenue vs Market: CVSG's revenue (6.1% per year) is forecast to grow faster than the UK market (4.8% per year).
High Growth Revenue: CVSG's revenue (6.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CVSG's Return on Equity is forecast to be high in 3 years time (21.4%)
How has CVS Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CVSG has high quality earnings.
Growing Profit Margin: CVSG's current net profit margins (3.8%) are higher than last year (1.3%).
Past Earnings Growth Analysis
Earnings Trend: CVSG's earnings have grown by 7.5% per year over the past 5 years.
Accelerating Growth: CVSG's earnings growth over the past year (238.6%) exceeds its 5-year average (7.5% per year).
Earnings vs Industry: CVSG earnings growth over the past year (238.6%) exceeded the Healthcare industry 88.1%.
Return on Equity
High ROE: CVSG's Return on Equity (10.1%) is considered low.
How is CVS Group's financial position?
Financial Position Analysis
Short Term Liabilities: CVSG's short term assets (£101.4M) exceed its short term liabilities (£98.5M).
Long Term Liabilities: CVSG's short term assets (£101.4M) do not cover its long term liabilities (£194.9M).
Debt to Equity History and Analysis
Debt Level: CVSG's net debt to equity ratio (26.5%) is considered satisfactory.
Reducing Debt: CVSG's debt to equity ratio has reduced from 212% to 44.1% over the past 5 years.
Debt Coverage: CVSG's debt is well covered by operating cash flow (71.4%).
Interest Coverage: CVSG's interest payments on its debt are well covered by EBIT (5.7x coverage).
What is CVS Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CVSG's dividend (0.33%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.41%).
High Dividend: CVSG's dividend (0.33%) is low compared to the top 25% of dividend payers in the UK market (4.08%).
Stability and Growth of Payments
Stable Dividend: CVSG is not paying a notable dividend for the UK market, therefore no need to check if payments are stable.
Growing Dividend: CVSG is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: CVSG is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CVSG's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Richard William Fairman (54 yo)
Mr. Richard Fairman serves as Chief Executive Officer of CVS Group plc since November 6, 2019 and is its Director since August 2018. Mr. Fairmanhas had been Chief Financial Officer at CVS Group plc since...
CEO Compensation Analysis
Compensation vs Market: Richard William's total compensation ($USD1.52M) is about average for companies of similar size in the UK market ($USD1.58M).
Compensation vs Earnings: Richard William's compensation has increased by more than 20% in the past year.
Experienced Management: CVSG's management team is considered experienced (2.2 years average tenure).
Experienced Board: CVSG's board of directors are considered experienced (3.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CVSG insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CVS Group plc's employee growth, exchange listings and data sources
- Name: CVS Group plc
- Ticker: CVSG
- Exchange: AIM
- Founded: 1999
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: UK£1.384b
- Shares outstanding: 70.97m
- Website: https://www.cvsukltd.co.uk
Number of Employees
- CVS Group plc
- CVS House
- Owen Road
- IP22 4ER
- United Kingdom
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/23 18:48|
|End of Day Share Price||2022/01/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.